Carlin Chang
Lika, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Age-Associated Patterns of Cardiovascular Risk and Disease Phenotypes Across Diverse Care Settings: The GLOB-cAGE Consortium.
Journal: American journal of physiology. Heart and circulatory physiology
Published: August 08, 2026
Risk-Guided Screening for Atrial Fibrillation Using Electronic Health Records.
Journal: Circulation
Published: July 28, 2026
Metformin use is associated with lower risks of dementia, anxiety and depression: The Hong Kong diabetes study.
Journal: Asian journal of psychiatry
Published: February 09, 2024
New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: a Chinese population-based cohort study.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: September 26, 2023
Initiation of warfarin is associated with decreased mortality in patients with infective endocarditis: A population-based cohort study.
Journal: Thrombosis research
Published: July 07, 2023
The Association Between Neutrophil-Lymphocyte Ratio and Variability with New-Onset Dementia: A Population-Based Cohort Study.
Journal: Journal of Alzheimer's disease : JAD
Published: June 11, 2023
The Impact of Cardiac Comorbidity Sequence at Baseline and Mortality Risk in Type 2 Diabetes Mellitus: A Retrospective Population-Based Cohort Study.
Journal: Life (Basel, Switzerland)
Published: October 09, 2022
Predictive value of neutrophil-to-lymphocyte ratio for atrial fibrillation and stroke in type 2 diabetes mellitus: The Hong Kong Diabetes Study.
Journal: Endocrinology, diabetes & metabolism
Published: September 11, 2022
Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes.
Journal: Rheumatology (Oxford, England)
Published: April 25, 2022
Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients: A Propensity Score-Matched Study in Hong Kong.
Journal: Cardiovascular drugs and therapy
Published: January 25, 2022
Hip fractures risks in edoxaban versus warfarin users: A propensity score-matched population-based cohort study with competing risk analyses.
Journal: Bone
Published: September 19, 2021
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis.
Journal: Frontiers in cardiovascular medicine
Published: July 26, 2021
Last Updated: 09/26/2026